Screener
Revolution Medicines, Inc. RVMD Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s total liabilities?
- Revolution Medicines, Inc. (RVMD) reported total liabilities of $753.82M in Q1 2026.
- How has Revolution Medicines, Inc.'s total liabilities changed year-over-year?
- Revolution Medicines, Inc.'s total liabilities increased by 162.5% year-over-year, from $287.2M to $753.82M.
- What is the long-term trend for Revolution Medicines, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s total liabilities has grown at a 50.8% compound annual growth rate (CAGR), from $92.73M to $723.21M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Revolution Medicines, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude